Specialists in glycosaminoglycans, biomolecules with a high therapeutic value

More than 20 million patients worldwide have been treated with our chondroitin sulfate

Since its foundation in 1975, Bioibérica has shown a strong commitment with the health of people. In these four decades, we have specialized in the research, production, and marketing of glycosaminoglycans, biomolecules of animal origin with high biological and therapeutic value, for the pharmaceutical industry. Specifically, the company is the world leader in heparin and in medicinal products and active ingredients for joint health.

One out of every 5 doses of heparin comes from Bioibérica

Heparin is the most widely used anticoagulant and antithrombotic drug. Twenty percent of heparin administered worldwide is manufactured by Bioibérica. And this is also the 20% of best quality. Bioibérica controls the whole life of the product, from extraction and development to marketing, in order to ensure excellence in each of the steps of the process.

Osteoarthritis, joint lesions and other disorders

One of our priorities is to improve the quality of life of the over 200 million patients in the world who suffer from osteoarthritis, joint lesions and muscular-skeletal disorders. Therefore, as well as Heparin, at Bioibérica we produce other biomolecules, like Chondroitin Sulfate, Glucosamine, Hyaluronic Acid or Collagen, indicated for the treatment of these illnesses.

High therapeutic value biomolecules

Bioiberica is a biotechnology company specialised in biomolecules with a high biological and therapeutic value that are extracted from different tissues of animal origin. It is a world leader in Heparin (the most widely used anticoagulant and antithrombotic drug) and in Chondroitin Sulfate (a slow symptomatic action drug for Osteoarthritis). The company is constantly searching for new solutions to improve the quality of life of people. 



    Telephone number:
    +34 93 490 49 08
    +34 93 490 97 11